Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Cannabotech ( (IL:CNTC) ) just unveiled an update.
Cannabotech has appointed Peri Amsalem as a regular director, effective February 10, 2025. Amsalem, who has experience as a capital market advisor and reporter, brings a fresh perspective to the company’s board, though he is not viewed as possessing accounting or financial expertise by the company. This strategic appointment indicates Cannabotech’s effort to strengthen its governance structure as it navigates the competitive landscape of the biotech industry.
More about Cannabotech
Cannabotech operates in the biotechnology industry, focusing on the development of cannabis-based products. The company is engaged in creating solutions that combine medicinal cannabis and various health technologies, aiming to innovate within the health and wellness sector.
YTD Price Performance: -26.42%
Average Trading Volume: 11,328
Find detailed analytics on CNTC stock on TipRanks’ Stock Analysis page.
